Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes

Diabetologia

Volumn 58, Issue 10, 2015, Pages 2247-2253

  Thomsen, Reimar W ^a   Baggesen, Lisbeth M ^a   Søgaard, Mette ^a   Pedersen, Lars ^a   Nørrelund, Helene ^a   Buhl, Esben S ^b   Haase, Christiane L ^b   Johnsen, Søren P ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Antidiabetic agents; Clinical quality; Comparative effectiveness; Glucose lowering therapy; Glycaemic control; HbA1c; Hypoglycaemic agents; Metformin; Pharmacoepidemiology; Type 2 diabetes

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; HEMOGLOBIN A1C; INSULIN; LIRAGLUTIDE; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; SULFONYLUREA DERIVATIVE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; DENMARK; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT DURATION; ANALYSIS; BLOOD; COMBINATION DRUG THERAPY; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 84942192266     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3698-1     Document Type: Article

References (9)

1. Lipska KJ, Krumholz HM (2014) Comparing diabetes medications: where do we set the bar? JAMA Intern Med 174:317–318
2. Roumie CL, Greevy RA, Grijalva CG et al (2014) Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. JAMA 311:2288–2296
3. Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC (2010) The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis. Diabetes Care 33:1859–1864
4. American Diabetes Association (2015) Standards of medical care in diabetes-2015: summary of revisions. Diabetes Care 38(suppl 1):S4
5. Agency for Healthcare Research and Quality (AHRQ) (2011) Medicines for type 2 diabetes: a review of the research for adults. Available from: http://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=721, accessed 15 April 2015
6. Thomsen RW, Baggesen LM, Svensson E et al (2015) Early glycaemic control among patients with type 2 diabetes and initial glucose-lowering treatment: a 13-year population-based cohort study. Diabetes Obes Metab 17:771–780
7. Pottegard A, Bjerregaard BK, Larsen MD et al (2014) Use of exenatide and liraglutide in Denmark: a drug utilization study. Eur J Clin Pharmacol 70:205–214
8. Wallia A, Molitch ME (2014) Insulin therapy for type 2 diabetes mellitus. JAMA 311:2315–2325
9. Raebel MA, Ellis JL, Schroeder EB et al (2014) Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study. Pharmacoepidemiol Drug Saf 23:699–710